Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy

Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H
פורמט: Journal article
שפה:English
יצא לאור: Elsevier 2014